The Calgary Retina Consultants have conducted numerous multicenter clinical trials, including:

- Protein Kinase C Beta Inhibitor Studies (Diabetic Retinopathy)
- Sandostatin LAR Study (in NPDR/PDR)
- EyeTech Study (Anti-VEGF Aptomer for AMD 1004/1012)
- Allergan Posurdex RVO (Retinal Vein Occlusion)
- VIO Study (Verteporfin in Occult AMD)
- VAM Study (Verteporfin in AMD)
- Retinal Study (Verteporfin and Kenalog in AMD)
- Allergan Posurdex DME (Diabetic Study)

Fellowship Program
The Calgary Retina Consultants is a busy private practice pure retinal group. We offer primarily a clinical fellowship with clinical research opportunities. The two year fellowship program is structured to provide a balance of medical and surgical comprehensive vitreal retinal experience. The group practice is community based and offers state of the art equipment for diagnosis and treatment in the clinic and surgical areas. The fellowship experience is anticipated to be dynamic, clinically busy and fosters increasing responsibilities towards a comprehensive vitreoretinal surgeon. The fellowship program would be supported by the University of Calgary Faculty of Medicine.